Robert received a PhD in Pathology studying the role of cerebral vascular dysfunction in Alzheimer’s disease at the University of Rochester. He then completed an AHA funded postdoctoral fellowship in cardiovascular biology and held a Research Assistant Professor position in the Department of Neurosurgery at the University of Rochester Medical Center. He joined Pfizer’s Neuroscience Research Unit in 2012 and built a preclinical research lab focused on vascular targets in central nervous system (CNS) disorders and drug delivery across the blood-brain barrier.
In 2017, Robert joined the Rare Disease Research Unit where he leads a group focused on developing novel AAV-based gene therapies for the rare neurological conditions. Robert has an interest in understanding molecular mechanisms that regulate AAV biodistribution and cellular trafficking at the blood-brain barrier and in the CNS.